Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Respiration ; 102(11): 934-943, 2023.
Article in English | MEDLINE | ID: mdl-37899038

ABSTRACT

BACKGROUND: Children exposed to a tuberculosis (TB) index case are at risk of TB infection and disease. OBJECTIVES: The aim of this study was to describe the proportion of child contacts who developed TB infection or disease after exposure and to assess the diagnostic pathways and adherence to current guidelines. METHODS: Retrospective observational study including children ≤16 years of age who had contact to a TB index case between January 2019 and July 2021. Analysis was stratified by age groups 0-4, 5-11, and 12-16 years. RESULTS: Of 401 TB-exposed children, data were available for 380 (95%). Of those, 7 (2%) were diagnosed with TB disease and 35 (9%) with TB infection. We identified several deviations in the management compared to recommendations in national Swiss guidelines: In the children aged 0-4 years, only 82% were examined with an immunodiagnostic test or a chest radiography within 2 weeks after last contact. Recommended prophylactic treatment was prescribed in 66% of the children only. In the children aged 5-11 years, 64% were tested with an immunodiagnostic test in a first examination and 75% in a second examination, 2 weeks and 2 months after last contact, respectively. CONCLUSIONS: Contact investigations of children exposed to a TB index case identified a significant proportion of children with TB infection and disease in a low TB incidence setting. We observed significant deviations from the guidelines in the contact investigations suggesting the need for improved implementation.


Subject(s)
Latent Tuberculosis , Tuberculosis , Adolescent , Child , Humans , Guideline Adherence , Latent Tuberculosis/diagnosis , Switzerland/epidemiology , Tuberculin Test , Tuberculosis/diagnosis , Tuberculosis/epidemiology , Retrospective Studies
2.
J Med Internet Res ; 24(3): e24582, 2022 03 11.
Article in English | MEDLINE | ID: mdl-35275065

ABSTRACT

Health care delivery is undergoing a rapid change from traditional processes toward the use of digital health interventions and personalized medicine. This movement has been accelerated by the COVID-19 crisis as a response to the need to guarantee access to health care services while reducing the risk of contagion. Digital health scale-up is now also vital to achieve population-wide impact: it will only accomplish sustainable effects if and when deployed into regular health care delivery services. The question of how sustainable digital health scale-up can be successfully achieved has, however, not yet been sufficiently resolved. This paper identifies and discusses enablers and barriers for scaling up digital health innovations. The results discussed in this paper were gathered by scientists and representatives of public bodies as well as patient organizations at an international workshop on scaling up digital health innovations. Results are explored in the context of prior research and implications for future work in achieving large-scale implementations that will benefit the population as a whole.


Subject(s)
COVID-19 , Telemedicine , Humans , Telemedicine/methods
3.
J Cell Biol ; 203(5): 757-66, 2013 Dec 09.
Article in English | MEDLINE | ID: mdl-24322427

ABSTRACT

Antigen preservation for presentation is a hallmark of potent antigen-presenting cells. In this paper, we report that in human macrophages and dendritic cells, a subset of phagosomes gets coated with Atg8/LC3, a component of the molecular machinery of macroautophagy, and maintains phagocytosed antigens for prolonged presentation on major histocompatibility complex class II molecules. These Atg8/LC3-positive phagosomes are formed around the antigen with TLR2 agonists and require reactive oxygen species production by NOX2 for their generation. A deficiency in the NOX2-dependent formation of these antigen storage phagosomes could contribute to compromise antifungal immune control in chronic granulomatous disease patients.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Antigen Presentation , Autophagy/physiology , Histocompatibility Antigens Class II/metabolism , Microfilament Proteins/metabolism , Phagosomes/metabolism , Autophagy-Related Protein 8 Family , Humans , Membrane Glycoproteins/metabolism , Membrane Glycoproteins/physiology , NADPH Oxidase 2 , NADPH Oxidases/metabolism , NADPH Oxidases/physiology , Phagosomes/physiology , Reactive Oxygen Species/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...